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by Christopher Coenen and Arianna Ferrari, 
ITAS
The overarching goal of “Ethics in Public 
Policy-Making: The Case of Human Enhance-
ment” (EPOCH) was to broaden and deepen 
knowledge of the role of ethics in the govern-
ance of new and emerging science and tech-
nology (NEST), taking the topic of “human 
enhancement” as the main case example. 
Comparative analyses of relevant institutions 
and current governance and normative frame-
works at European and national level (includ-
ing non-EU countries and taking into account 
selected non-European countries) have been 
conducted, and detailed studies on the topic 
of human enhancement and its governance 
have been carried out. Launched in Novem-
ber 2010, the recently completed project EP-
OCH was funded by the European Commis-
sion in the Seventh Framework Programme 
and coordinated by the University of Bristol. 
Other partners were the Institute for Technol-
ogy Assessment and Systems Analysis (ITAS) 
within Karlsruhe Institute of Technology (KIT), 
the universities of Padua, Aarhus, Ljubljana, 
Maastricht, Swansea, Singapore and Cal-
gary, and the French Centre National de la 
Recherche Scientifique. In the following, the 
main results of EPOCH work packages led by 
ITAS will be presented, above all concerning 
the topic of human enhancement.
1 Introduction
ITAS was one of the main partners in EPOCH, 
which aimed to broaden and deepen knowledge 
of the role of ethics in the governance of ethical-
ly controversial NEST. The project focused on 
new and emerging bio- and neuro-technologies 
and on the topic of human enhancement, includ-
ing doping in sports. Area 2 of the project, which 
was led by ITAS, dealt with the topic of human 
enhancement and the related challenges for Eu-
ropean policy making. Besides various empirical 
and theoretical studies, an expert workshop on 
the governance and ethics of human enhance-
ment was organised in Karlsruhe in March 2012. 
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2 The State of the Art in Technoscientific 
Fields Potentially Relevant to Human 
Enhancement
How did EPOCH define “human enhancement”? 
Building on older projects such as a STOA study 
on the topic (Coenen et al. 2009), it was under-
stood as any “modification aimed at improv-
ing individual human performance and brought 
about by science-based or technology-based 
interventions in the human body”. A distinction 
was made between (i) restorative or preventive, 
non-enhancing interventions, (ii) therapeutic en-
hancements, and (iii) non-therapeutic enhance-
ments, focusing in our analysis on non-thera-
peutic enhancements since they are at the core 
of discourse on human enhancement. Human en-
hancement was primarily regarded as a specific 
perspective on developments in science, technol-
ogy, medicine and society, and “human enhance-
ment technologies” (HET) therefore less as a 
field of technologies and more as a number of 
technologies subsumed to a certain, ideological-
ly framed goal. This definition includes “strong” 
forms of human enhancement with long-term 
effective or permanent results (e.g. genetic en-
hancements and invasive brain-computer inter-
faces) as well as “temporary” enhancements (e.g. 
alleged “pharmacological cognitive enhancers”). 
In its state of the art analyses concerning HET, 
the project focused on cognitive enhancement 
(pharmacological cognitive enhancement, in par-
ticular) and on physical enhancement, although 
to a certain extent it also took into account so-
called “mood enhancement”.
Pharmacological cognitive enhancement 
(PCE) is an area in which non-therapeutic en-
hancements are widely discussed. It has already 
received considerable attention in both academ-
ic and policy discourse on human enhancement 
and its ethical and societal implications, as well 
as (in some countries) in the mass media. Al-
though there is extensive literature on ethical, 
legal and societal aspects (ELSA) of PCE, there 
is very scant empirical evidence of the effective-
ness of these substances in healthy individuals. 
There are major obstacles to assessing the cur-
rent state of the art in this area due to the lack of 
data relating to such use of these substances and 
other aspects. Early discourse on PCE focused 
on ethical issues and future uses of drugs that do 
not as yet exist and thus to a large extent contrib-
uted only to what has been termed “speculative 
ethics” (Nordmann 2007; Nordmann/Rip 2009). 
While this highly speculative discourse con-
tinues, scientists, psychiatrists, other medical 
experts, philosophers, social scientists, science 
journalists and researchers in the field of tech-
nology assessment have at the same time been 
drawing attention to and taking issue with the 
problematic features of discourse on PCE (see, 
for example, Lucke et al. 2011; Quednow 2011). 
In line with and in parallel to these criticisms, 
the EPOCH analyses of the state of the art in 
PCE came to the following conclusions:
 • There is no evidence in the literature that any 
substance can enable a person to develop ex-
traordinary (or superhuman) capabilities.
 • In the existing literature it is not clear whether 
some substances could allow a person to in-
crease their particular cognitive ability beyond 
his/her own optimal level (i.e. when not suf-
fering stress, repetitive conditions or sleep 
deprivation).
 • There is growing evidence that it is not scien-
tifically sound to speak of “cognitive enhanc-
ers” for healthy individuals: if a substance can 
be proved to have an enhancing effect, this 
effect is always on a particular property of 
cognition, and is often differently interrelated 
with changes in other properties (which can 
also be detrimental).
 • Comparative studies of different substances 
have found that each substance may produce 
different advantages (if they produce any at 
all) depending on the cognitive demands of 
the task.
 • Caffeine (600 mg), dextroamphetamine 
(20 mg) and modafinil (400 mg) have an 
equal effect on objective alertness and simple 
psychomotor performance for approximately 
two to four hours, although the side-effects 
and addiction potential of those substances 
vary substantially.
 • Stimulants sometimes have a placebo effect: 
the mere expectation of receiving a stimulant 
can raise subjective arousal.
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Doubts have also been expressed concerning 
the extent to which these substances are actu-
ally used and regarding their potential attractive-
ness for broader parts of the population. It is no 
wonder then that the Office of Technology As-
sessment at the German Parliament (TAB), after 
its own major study on PCE (Sauter/Gerlinger 
2012), has concluded that the hype surround-
ing PCE has been “demystified”. The TAB also 
pointed out that potential pro-PCE policies face 
very considerable hurdles. There is obviously a 
trend towards challenging central assumptions 
about the efficacy of the drugs in question and 
the societal relevance of their use which were 
widely held in early discourse on PCE. Highly 
speculative ethical discourse in particular has 
been strongly criticised since 2011.
“Neurotechnological enhancement” (NCE) 
– which according to the definitions proposed by 
EPOCH encompasses not only all kinds of neu-
rotechnological implants, but also those stimula-
tion technologies which do not require surgery 
– has to date been almost completely therapeutic. 
Given its main applications in therapies, it ap-
pears almost frivolous to speculate on the non-
therapeutic use of such technologies to enhance 
the performance of people without serious health 
problems. The body-external brain stimulation 
technologies that appear to be most relevant in 
the context of non-therapeutic applications are 
transcranial magnetic stimulation (TMS) and 
transcranial direct current stimulation (TDCS). 
While some of the technologies are only efficient 
when applied during sleep, others can be used 
during learning. Enhancing effects of such stim-
ulation technologies that have been observed so 
far have only been transient improvements, how-
ever. Brain-computer interfaces (BCI), which 
can be implanted or used in body-external de-
vices, do not stimulate the brain but use neural 
signals as input for purposes such as the control 
of machines. BCI technologies are therefore not 
cognitive enhancers according to the definition 
proposed by EPOCH, but they are important in 
this context since they appear to herald a new 
quality in human-machine interaction and can 
improve human performance significantly and in 
a way similar to the visions of human enhance-
ment. The most important conclusion in this con-
text appears to be that the topic of NCE should be 
scrutinised in much the same way as PCE was, 
trying to help avoid another hype (which in the 
case of the hype around PCE might have contrib-
uted to the popularisation of useless and poten-
tially or actually harmful drugs).
The fact that neuro- and bio-technologies, 
BCIs and various other bio-signal based technol-
ogies, advances in limb prosthetics and robotics 
and other technoscientific fields appear to herald 
a massive and societally relevant change in the 
interrelations between humans and technology 
should not be overlooked or underestimated, 
however. It may well be the case that discourse 
on “human enhancement” will turn out to be just 
an early and strangely ideological harbinger of 
things to come.
3 The Role of Ethics in Governance 
Activities on Human Enhancement
The EPOCH project also produced an overview 
of existing policies and governance activities on 
selected enhancement issues and analysed how 
ethical issues are taken into account in these 
activities, focusing on activities on cognitive 
enhancement and on activities dealing with “hu-
man enhancement” (plus a separate work pack-
age on doping in sports) and on Europe. The col-
lection of information on governance activities 
was largely restricted to documents and activities 
which explicitly refer to discourse on and the no-
tion of “enhancement”. In general, the EPOCH 
project used a very broad notion of “govern-
ance”; this notion is also used in order to take 
into account well-known changes that have taken 
place in the science system and in research poli-
cies in the last two decades. The EPOCH project 
focused, however, on the interface between pol-
icy and academic spheres and, in particular, on 
policy advice regarding ethically controversial 
NEST. Accordingly, EPOCH research on the 
governance of human enhancement concentrated 
on (1) policy activities in the narrow sense (such 
as parliamentary activities), (2) activities of insti-
tutions that regularly give advice to policy mak-
ers, (3) activities of publicly funded institutions 
or other public bodies that play an important role 
within the science system (e.g. academies of sci-
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ence) or political system, (4) all kinds of pub-
licly funded “accompanying research” activities 
which explicitly deal with the topic of human 
enhancement and are conducted in such fields as 
technology assessment and studies on ELSA of 
relevant NEST, and (5) publicly funded “public 
dialogue” activities. Other activities were only 
taken into account if core actors in the political 
system or science system participated in them 
or if they were directly funded by political in-
stitutions or by institutions of policy advice. The 
focal countries in these analyses were Croatia, 
Denmark, France, Germany, Italy, Netherlands, 
Norway, Poland, Serbia, Slovenia, Spain, Swit-
zerland and the United Kingdom. Activities in 
other European countries were not systematical-
ly taken into account. This selection of countries 
had the goal of supporting Pan-European reflec-
tion on the role of ethics in science and technol-
ogy governance and policy making and on the 
topic of human enhancement.
The analyses showed that the selected coun-
tries can be roughly divided into two groups: a 
group of countries in which a large number of 
activities or high‐profile activities are taking 
place (Denmark, Germany, the Netherlands, 
Norway, the United Kingdom and Switzerland), 
and a group of countries in which there is lively 
academic discourse but governance activities 
are rare or non‐existent, or in which both aca-
demic discussions and governance activities are 
very rare or non-existent (Croatia, France, Italy, 
Poland, Serbia, Slovenia and Spain). Ethical as-
pects play a major role in a large number of ac-
tivities on human enhancement. Policy activities 
in the narrow sense (such as parliamentary ac-
tivities) are very rare. A few parliamentary com-
mittees have dealt with the topic, mainly in the 
context of technology assessment, foresight or 
ELSA research activities or in connection with 
doping policies. It is therefore much too early to 
identify trends in governance activities on this 
topic in Europe.
As mentioned above, academic discourse on 
cognitive enhancement has changed significantly 
very recently – shifting from highly speculative 
discussions to a more evidence‐based discourse 
– but this has only rarely been taken into account 
by governance activities so far. Although some 
new publications by policy advisory institutions 
reflect this shift (see, for example, Eckhardt et al. 
2011; Sauter/Gerlinger 2012), it would be pre-
mature to define this as a new trend. The same 
holds true for the apparent, related shift in aca-
demic discourse on cognitive enhancement from 
pharmacological to neurotechnological means of 
enhancement. Again, we find some new publi-
cations by policy advisory institutions here that 
appear to reflect this shift, yet it is also still too 
early to say whether this constitutes a trend. An 
interesting trend might be constituted by the fact 
that the enhancement of military performance 
is pursued to some degree in Europe. In early 
discourse explicitly focused on human enhance-
ment (in the first half of the 2000s), it was often 
pointed out that U.S. military research plays an 
important role in discussions and other activi-
ties on human enhancement and that military 
enhancement is an irrelevant topic in Europe. In 
the meantime, however, a small number of ac-
tivities on this topic have been taking place in the 
EU, though largely in the form of “preparatory” 
ELSA and foresight research.
If we look at how reports by policy advisory 
institutions (such as national ethics councils or 
technology assessment offices) in the selected 
countries have related and contributed to ethical 
discourse, we can observe, amongst other things, 
the following:
 • The lack of a universally accepted definition 
of the term enhancement and the problematic 
distinction between enhancement and therapy 
are perceived as a major challenge for the 
ethical debate in the majority of documents 
on this topic.
 • The question of what human nature is, that is 
to say the anthropology beyond technological 
development, is discussed as a central ethical 
issue, and the discussion is characterised by 
a polarisation of positions between radical 
promoters of the creation of biologically and 
technologically superior human beings on the 
one hand, and those on the other hand who 
stress that nature and character are morally 
valuable categories and rely on concepts such 
as finitude and humility.
 • The anthropological aspects of the signifi-
cance of humankind and its relationships with 
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technologies concern not only the individual 
but also the societal level.
 • There is a discussion of the role of intuitions 
in the ethical arguments
 • Broader societal processes, such as changes 
in the health system, are relevant to the topic 
of human enhancement.
Since enhancement is a complex, multifaceted 
phenomenon, speculation about what these 
technologies could do in future and which kind 
of ethical issues we will be confronted with 
play a major role in the governance debate. In 
this respect we can identify two major trends: 
on the one hand, the reference to the future and 
to visions of increasing human performance by 
technological means is seen as a possible future 
scenario and is analysed by means of foresight. 
On the other hand, although a lack of evidence 
of efficacy or a lack of empirical studies of cer-
tain effects of some technologies is stated, the 
discussion of the ethical issues as well as the 
formulation of governance recommendations is 
still often framed by the idea that these tech-
nologies will be developed sooner or later and 
will thus become a concrete and urgent issue 
needing to be faced.
One of the major challenges for the govern-
ance of ethically controversial NEST is posed 
by the fact that different ethical values co-exist, 
with the result that a technology may be differ-
ently evaluated in society. Ethical pluralism is 
not explicitly addressed as a theoretical problem 
in institutional reports, but is implicitly taken 
into consideration in the formulation of policy 
recommendations. In this respect we can identify 
three major trends in the way the reports ana-
lysed in EPOCH have issued policy and govern-
ance recommendations:
1. In some cases, policy recommendations opt 
clearly for a particular type of regulation.
2. In other cases, the presence of different ethi-
cal views is openly declared and different 
governance frameworks (or different recom-
mendations) are formulated.
3. In yet other cases, some reports list different 
ethical arguments, acknowledge the possi-
bility of different regulatory frameworks and 
conclude with open questions which should 
be addressed in order to clarify political de-
cisions.
It is interesting to note that recommendations are 
often presented in the form of alternative routes 
of action tied to specific ethico-political ap-
proaches or stances. This fact can be interpreted 
as a further sign of cultural diversity in Europe 
with regard to the topic of enhancement. This 
diversity is not restricted to differences between 
national cultures but encompasses cultural dif-
ferences within countries. It also indicates that 
practices and visions of human enhancement are 
raising challenges that are related to unresolved 
questions in Europe’s common cultural and po-
litical history (for example with regard to the 
legacies of Western and Russian utopianism and 
of eugenics). What significance this has for the 
role of ethics in governance activities on human 
enhancement issues is a topic that deserves fur-
ther scrutiny in the future.
4 Outlook
In this article, we have only presented a rela-
tively small selection of EPOCH project results, 
focusing on research done or led by ITAS. The 
project has, however, successfully combined its 
various thematic strands, both in analyses and in 
workshops, conferences and meetings. Besides a 
number of recommendations for the governance 
of human enhancement and for doping in sports, 
a major outcome of the project will be recom-
mendations for policy makers and stakeholder 
groups concerning how to help improve policy 
advice on ethically controversial NEST in Eu-
rope.1 The main challenges in the latter regard 
appear to include how to intensify and improve 
the exchange of information and ideas within Eu-
rope and how to foster interdisciplinary, multi-
stakeholder and public deliberations in this area.
Note
1) These recommendations – as well as several work-
shop and other reports and outputs of the project – 
will be published in the coming months on the EP-
OCH project website (http://epochproject.com/) 
and on the ITAS website (http://www.itas.kit.edu). 
TA-PROJEKTE
Technikfolgenabschätzung – Theorie und Praxis 21. Jg., Heft 3, Dezember 2012  Seite 85
Various recent and forthcoming academic publi-
cations also present results of the EPOCH project 
(e.g. Ferrari et al. 2012; Mali et al. 2012).
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